Ginkgo Bioworks' Autonomous Laboratory Driven by OpenAI's GPT-5 Achieves 40% Improvement Over State-of-the-Art Scientific Benchmark

Ginkgo Bioworks announced that an artificial intelligence system it developed with OpenAI autonomously designed, executed and learned from biological experiments using the company's cloud laboratory infrastructure. The system combined OpenAI's GPT-5 reasoning model with Ginkgo's reconfigurable automation carts technology and Catalyst automation software. In a preprint the collaborators reported that the GPT-5-driven autonomous lab reduced cell-free protein synthesis reaction costs The autonomous lab executed more than 36,000 experimental conditions in six rounds over six months. It ran more than 580 384-well plates and generated nearly 150,000 data points. Human involvement was limited primarily to reagent preparation, loading and unloading, and system oversight. The model proposed and prioritized new reagents to test, some of which anticipated findings from published research. Ginkgo said it is now selling the AI-improved reaction mix in its reagents store. The findings are described in a preprint available on OpenAI's website.